Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
Clinical trial NCT05524935 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05524935
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-11
- Primary completion
- 2026-07-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.